Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Quaife

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
BMC Infectious Diseases|November 11, 2021
Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trialAmare W Tadesse, Zemedu Mohammed, Nicola Foster, et al.
The Lancet. Global Health|November 19, 2021
Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelaeNicolas A Menzies, Matthew Quaife, Brian W Allwood, et al.
Plos Medicine|January 24, 2023
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling studyAllison Portnoy, Rebecca A Clark, Matthew Quaife, et al.
The Lancet. Global Health|March 16, 2023
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling studyRebecca A Clark, Christinah Mukandavire, Allison Portnoy, et al.
JMIR Formative Research|May 23, 2022
Key Drivers and Facilitators of the Choice to Use mHealth Technology in People With Neurological Conditions: Observational StudySara Simblett, Mark Pennington, Matthew Quaife, et al.
Trials|April 24, 2023
Evaluating the equity impact and cost-effectiveness of digital adherence technologies with differentiated care to support tuberculosis treatment adherence in Ethiopia: protocol and analysis plan for the health economics component of a cluster randomised trialNicola Foster, Amare W Tadesse, Christopher Finn McQuaid, et al.
BMJ Global Health|December 3, 2021
Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countriesSergio Torres-Rueda, Sedona Sweeney, Fiammetta Bozzani, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 8, 2022
End-point definition and trial design to advance tuberculosis vaccine developmentAlberto L Garcia-Basteiro, Richard G White, Dereck Tait, et al.
Journal of the International AIDS Society|February 3, 2021
Estimating the contribution of key populations towards HIV transmission in South AfricaJack Stone, Christinah Mukandavire, Marie-Claude Boily, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
BMC Infectious Diseases|November 11, 2021
Evaluation of implementation and effectiveness of digital adherence technology with differentiated care to support tuberculosis treatment adherence and improve treatment outcomes in Ethiopia: a study protocol for a cluster randomised trialAmare W Tadesse, Zemedu Mohammed, Nicola Foster, et al.
The Lancet. Global Health|November 19, 2021
Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelaeNicolas A Menzies, Matthew Quaife, Brian W Allwood, et al.
Plos Medicine|January 24, 2023
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling studyAllison Portnoy, Rebecca A Clark, Matthew Quaife, et al.
The Lancet. Global Health|March 16, 2023
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling studyRebecca A Clark, Christinah Mukandavire, Allison Portnoy, et al.
JMIR Formative Research|May 23, 2022
Key Drivers and Facilitators of the Choice to Use mHealth Technology in People With Neurological Conditions: Observational StudySara Simblett, Mark Pennington, Matthew Quaife, et al.
Trials|April 24, 2023
Evaluating the equity impact and cost-effectiveness of digital adherence technologies with differentiated care to support tuberculosis treatment adherence in Ethiopia: protocol and analysis plan for the health economics component of a cluster randomised trialNicola Foster, Amare W Tadesse, Christopher Finn McQuaid, et al.
BMJ Global Health|December 3, 2021
Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countriesSergio Torres-Rueda, Sedona Sweeney, Fiammetta Bozzani, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|June 8, 2022
End-point definition and trial design to advance tuberculosis vaccine developmentAlberto L Garcia-Basteiro, Richard G White, Dereck Tait, et al.
Journal of the International AIDS Society|February 3, 2021
Estimating the contribution of key populations towards HIV transmission in South AfricaJack Stone, Christinah Mukandavire, Marie-Claude Boily, et al.
Pageof 9